CCMINC
Cardinal Capital Management Inc (North Carolina) Portfolio holdings
AUM
$681M
1-Year Return
15.1%
This Quarter Return
+6.18%
1 Year Return
+15.1%
3 Year Return
+57.39%
5 Year Return
+116.47%
10 Year Return
+269.09%
AUM
$681M
AUM Growth
+$35.7M
(+5.5%)
Cap. Flow
+$7.68M
Cap. Flow
% of AUM
1.13%
Top 10 Holdings %
Top 10 Hldgs %
26.05%
Holding
132
New
–
Increased
111
Reduced
16
Closed
4
Top Buys
| 1 |
JPMorgan Chase
JPM
|
+$1.28M |
| 2 |
Apple
AAPL
|
+$816K |
| 3 |
Johnson & Johnson
JNJ
|
+$580K |
| 4 |
Phibro Animal Health
PAHC
|
+$552K |
| 5 |
Hasbro
HAS
|
+$539K |
Top Sells
| 1 |
Pfizer
PFE
|
+$2.41M |
| 2 |
Elbit Systems
ESLT
|
+$1.77M |
| 3 |
Dow Inc
DOW
|
+$1.12M |
| 4 |
Amcor
AMCR
|
+$986K |
| 5 |
Helios Technologies
HLIO
|
+$812K |
Sector Composition
| 1 | Technology | 21.46% |
| 2 | Healthcare | 20.17% |
| 3 | Industrials | 15.05% |
| 4 | Financials | 13.42% |
| 5 | Consumer Staples | 10.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Bristol-Myers Squibb
BMY
$94B
| $4.68M | 0.69% |
101,073
+3,414
| +3% | +$158K |
|
52
Regeneron Pharmaceuticals
REGN
$59.4B
| $4.37M | 0.64% |
8,316
+280
| +3% | +$147K |
|
53
PepsiCo
PEP
$197B
| $4.36M | 0.64% |
33,004
+808
| +3% | +$107K |
|
54
Morningstar
MORN
$10.8B
| $4.35M | 0.64% |
13,854
+1,519
| +12% | +$477K |
|
55
DexCom
DXCM
$29.9B
| $4.13M | 0.61% |
47,272
+1,703
| +4% | +$149K |
|
|
BCPC
56
Balchem Corporation
BCPC
$5.07B
| $4.12M | 0.6% |
25,878
+36
| +0.1% | +$5.73K |
|
57
Toyota
TM
$256B
| $4.09M | 0.6% |
23,755
+620
| +3% | +$107K |
|
58
FedEx
FDX
$54.2B
| $4.04M | 0.59% |
17,645
+711
| +4% | +$163K |
|
59
Shell
SHEL
$207B
| $4M | 0.59% |
56,767
+832
| +1% | +$58.6K |
|
60
Teledyne Technologies
TDY
$26.1B
| $3.89M | 0.57% |
7,592
+32
| +0.4% | +$16.4K |
|
61
CACI
CACI
$10.9B
| $3.88M | 0.57% |
8,134
-98
| -1% | -$46.7K |
|
|
62
Elbit Systems
ESLT
$23.6B
| $3.5M | 0.51% |
7,772
-3,935
| -34% | -$1.77M |
|
63
Snap-on
SNA
$17.4B
| $3.47M | 0.51% |
11,165
+124
| +1% | +$38.6K |
|
64
Sanofi
SNY
$115B
| $3.43M | 0.5% |
71,042
+2,038
| +3% | +$98.5K |
|
65
Novo Nordisk
NVO
$244B
| $3.42M | 0.5% |
49,576
+1,161
| +2% | +$80.1K |
|
66
United Therapeutics
UTHR
$18.3B
| $3.41M | 0.5% |
11,876
+177
| +2% | +$50.9K |
|
67
Masimo
MASI
$8.01B
| $3.4M | 0.5% |
20,237
+369
| +2% | +$62.1K |
|
68
Toronto Dominion Bank
TD
$131B
| $3.37M | 0.49% |
45,871
+659
| +1% | +$48.4K |
|
69
Landstar System
LSTR
$4.46B
| $3.37M | 0.49% |
24,234
+475
| +2% | +$66K |
|
70
Phillips 66
PSX
$52.9B
| $3.33M | 0.49% |
27,932
+1,242
| +5% | +$148K |
|
71
Scotiabank
BNS
$78.7B
| $3.32M | 0.49% |
60,074
+2,665
| +5% | +$147K |
|
72
Dolby
DLB
$6.85B
| $3.27M | 0.48% |
44,078
+763
| +2% | +$56.7K |
|
73
InterDigital
IDCC
$8.33B
| $3.26M | 0.48% |
14,535
-4
| -0% | -$897 |
|
74
Huntington Bancshares
HBAN
$25.9B
| $3.14M | 0.46% |
185,804
+2,200
| +1% | +$37.2K |
|
75
Jack Henry & Associates
JKHY
$11.7B
| $3.09M | 0.45% |
17,161
+28
| +0.2% | +$5.05K |
|